• Onkologie · Apr 2004

    Case Reports

    Complete response of multiple melanoma brain metastases after treatment with temozolomide.

    • J Dvorak, B Melichar, J Zizka, D Hadzi-Nikolov, and J Petera.
    • Department of Oncology and Radiotherapy, Charles University Medical School and Teaching Hospital, Hradec Králové, Czech Republic. dvorakj@fnhk.cz
    • Onkologie. 2004 Apr 1; 27 (2): 171-4.

    BackgroundInoperable melanoma brain metastases are usually uniformly fatal, and complete response after cytotoxic therapy is rare.Case ReportA patient with multiple inoperable melanoma brain metastases was treated with 6 cycles of oral temozolomide (300 mg once daily over 5 days every 28 days). A complete response was documented by magnetic resonance.ConclusionsThe present observation suggests that temozolomide may be an active and well tolerated treatment for malignant melanoma brain metastases.Copyright 2004 S. Karger GmbH, Freiburg

      Pubmed     Full text   Copy Citation     Plaintext  

      Add institutional full text...

    Notes

     
    Knowledge, pearl, summary or comment to share?
    300 characters remaining
    help        
    You can also include formatting, links, images and footnotes in your notes
    • Simple formatting can be added to notes, such as *italics*, _underline_ or **bold**.
    • Superscript can be denoted by <sup>text</sup> and subscript <sub>text</sub>.
    • Numbered or bulleted lists can be created using either numbered lines 1. 2. 3., hyphens - or asterisks *.
    • Links can be included with: [my link to pubmed](http://pubmed.com)
    • Images can be included with: ![alt text](https://bestmedicaljournal.com/study_graph.jpg "Image Title Text")
    • For footnotes use [^1](This is a footnote.) inline.
    • Or use an inline reference [^1] to refer to a longer footnote elseweher in the document [^1]: This is a long footnote..

    hide…

What will the 'Medical Journal of You' look like?

Start your free 21 day trial now.

We guarantee your privacy. Your email address will not be shared.